Network meta-analysis of 15 RCTs (n=4395) in locally advanced laryngeal/hypopharyngeal SCC: cisplatin-based chemoradiotherapy ranked best for larynx preservation (SUCRA 0.73); non-surgical strategies beat surgery plus postoperative RT (HR 0.34).
Meta-analysisn = 4,395
Capriotti et al. Treatment of Locally Advanced Layngohypopharyngeal Cancers: A Network Meta-Analysis